Menu

Bifidobacterium longum: A Key Player in Gut Health Restoration

Bifidobacterium longum - A Key Player in Gut Health Restoration
Have you ever found yourself strolling down the probiotic aisle in your local healthfood store, seeing all of the bottles of bacteria that promise to make your gut a happy and healthy place, yet not knowing which one might actually be of help to you?  The first thing you want to do is get a stool test to have a look at your microbiome to see what is going on inside of you.  Once you are armed with that information, then you can figure out what good bacteria are missing.  Here we take a look at one specific strain of good bacteria for the gut, Bifidobacterium longum, and examine how supplementing it may help your health.
 
The gut microbiome is one very important factor that affects many aspects of human health, influencing not only digestive processes but also immune function, mental well-being, and even metabolic balance. Among the myriad of microorganisms inhabiting our gut, Bifidobacterium longum is a key beneficial bacterium, known for its profound impact on gut health restoration. In this post we will take a look at the mechanisms by which B. longum aids in restoring normal gut flora and improving overall health.
 

Understanding Gut Flora

The human gut harbors a complex ecosystem of trillions of microorganisms, collectively known as the gut microbiota. These microorganisms include bacteria, viruses, fungi, and archaea, which play crucial roles in maintaining digestive health, synthesizing vitamins, metabolizing nutrients, and modulating the immune system. A delicate balance within this microbiome is essential for optimal health, and disruptions can lead to various gastrointestinal disorders and systemic health issues.

Role of Bifidobacterium longum

Bifidobacterium longum, a species of bacteria belonging to the Bifidobacterium genus, is a predominant inhabitant of the human colon, particularly in breastfed infants. It possesses several attributes that make it a valuable probiotic for gut health restoration. B. longum produces short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, through the fermentation of dietary fibers. These SCFAs not only serve as an energy source for colonocytes but also exhibit anti-inflammatory properties and contribute to maintaining a healthy intestinal environment.

Furthermore, B. longum has been shown to enhance the integrity of the intestinal barrier by promoting the expression of tight junction proteins, thereby preventing the translocation of harmful pathogens and toxins across the gut epithelium. By competing for nutrients and adhesion sites, B. longum also inhibits the growth of pathogenic bacteria, such as Escherichia coli and Clostridium difficile, thus reducing the risk of intestinal infections and dysbiosis.

Restoring Normal Gut Flora

The disruption of the gut microbiota, termed dysbiosis, can result from various factors, including antibiotic use, poor diet, stress, and illness. Dysbiosis is associated with numerous gastrointestinal disorders, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and colorectal cancer, as well as systemic conditions like obesity, diabetes, and autoimmune diseases. Restoring normal gut flora is therefore crucial for alleviating symptoms and promoting overall health.

Supplementation with Bifidobacterium longum has been proposed as a strategy to rebalance the gut microbiota and restore microbial diversity. Clinical studies have demonstrated that B. longum supplementation can improve gastrointestinal symptoms in individuals with IBS, reduce inflammation in patients with IBD, and enhance immune function in healthy adults and the elderly. Moreover, B. longum has been shown to modulate the gut-brain axis, positively affecting mood, cognition, and stress resilience.

Bifidobacterium and its Probiotic Traits

The story of bifidobacteria dates back to 1899 when they were first isolated from the feces of breast-fed infants by Tissier. Since then, research has uncovered their presence in various ecological niches, highlighting their versatility and adaptability. However, despite their well-established health benefits, our understanding of the molecular mechanisms behind their probiotic traits remains incomplete.

Guardians of Gut Health:
Bifidobacteria’s Impact on Health and Disease

The gut microbiota, a diverse microbial community residing in the human gastrointestinal tract, plays a crucial role in maintaining health. Bifidobacteria, among other beneficial microbes, interact with their host in various ways, ranging from competitive exclusion of pathogens to modulation of the immune system.

Studies have linked compositional gut microbiota alterations to gastrointestinal diseases such as inflammatory bowel disease and necrotizing enterocolitis. In particular, bifidobacteria has shown promise in alleviating symptoms associated with these conditions, although the exact mechanisms remain unclear.

 

The Power of Bifidobacteria: Insights from Research

Bifidobacteria, a genus of probiotic bacteria, have garnered significant attention in scientific research across different microbiome-related conditions due to their potential health-promoting effects. These beneficial microbes are naturally found in the human gut and play a crucial role in maintaining a balanced microbiome. Recent studies have shed light on the various ways bifidobacteria can influence health, particularly in relation to colorectal cancer, diarrhea, inflammatory bowel disease, colon regularity, and the competitive exclusion of pathogens.

Colorectal Cancer

Colorectal cancer remains a major health concern worldwide, with increasing incidence rates. Emerging research indicates that certain strains of bifidobacteria possess anti-mutagenic properties, which means they can potentially prevent mutations that lead to cancer. These bacteria may protect DNA from carcinogenic damage, reducing the risk of developing colorectal cancer. For instance, a study published in the journal Gut Microbes highlighted the role of bifidobacteria in modulating the gut environment and inhibiting the growth of cancerous cells. The study suggested that the regular intake of bifidobacteria-rich foods or supplements could serve as a preventive strategy against colorectal cancer.

Diarrhea

Diarrhea, particularly in infants, is often caused by rotavirus, a highly contagious virus. Bifidobacteria have been shown to inhibit rotavirus, thereby reducing the incidence and severity of diarrhea. A landmark study published in the Journal of Pediatric Gastroenterology and Nutrition demonstrated that infants who received bifidobacteria supplements experienced fewer episodes of diarrhea compared to those who did not. This finding underscores the therapeutic potential of bifidobacteria in managing gastrointestinal disorders and highlights their role in promoting gut health from an early age.

Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), which includes conditions like Crohn’s disease and ulcerative colitis, is characterized by chronic inflammation of the digestive tract. While the exact mechanisms through which bifidobacteria exert their effects on IBD remain elusive, several studies have reported positive outcomes. Probiotic formulations containing bifidobacteria have shown efficacy in reducing inflammation and alleviating symptoms of IBD. For example, research published in Clinical Gastroenterology and Hepatology found that patients with IBD who consumed bifidobacteria-enriched probiotics experienced significant symptom relief and improved quality of life. These findings offer hope for more effective management strategies for IBD.

Colon Regularity

Digestive health is closely linked to colon regularity, and bifidobacteria play a vital role in this aspect. Studies have shown that the ingestion of fermented milk products containing bifidobacteria can improve colon regularity. A study published in the British Journal of Nutrition reported that participants who consumed bifidobacteria-rich yogurt experienced more regular bowel movements and reduced constipation. This suggests that incorporating bifidobacteria into the diet could be a natural way to promote digestive health and maintain a healthy gut.

Competitive Exclusion

The concept of competitive exclusion refers to the ability of beneficial bacteria to outcompete and inhibit the growth of harmful pathogens in the gut. Bifidobacteria excel in this role, preventing gastrointestinal infections by establishing a protective barrier. Research published in Microbial Ecology in Health and Disease demonstrated that bifidobacteria could effectively colonize the gut and inhibit the proliferation of pathogenic bacteria. This protective effect underscores the importance of maintaining a healthy population of bifidobacteria to defend against gut infections and support overall health.

 

 

Harnessing the Potential: Bifidobacteria in Functional Foods

The inclusion of bifidobacteria in functional foods has gained traction in recent years, with fermented dairy products serving as a common vehicle for delivering these beneficial microbes. Prebiotics, selectively fermented ingredients that modulate the gut microbiota, have also emerged as a strategy to promote the growth of bifidobacteria and enhance gut health.

Non-digestible oligosaccharides, such as fructo-oligosaccharides and galacto-oligosaccharides, have been shown to selectively increase bifidobacterial numbers in the gut, further underscoring their role as prebiotic agents.

 

Further Research

As our understanding of the gut microbiome continues to evolve, so too does the potential for leveraging probiotics like Bifidobacterium longum to optimize health outcomes. Future research endeavors may focus on elucidating the specific strains and mechanisms of action underlying the beneficial effects of B. longum and exploring innovative delivery systems to enhance probiotic viability and efficacy.

Bifidobacterium longum is a superb therapeutic agent for improving gut health and restoring normal gut flora. Through its multifaceted mechanisms of action, B. longum maintains intestinal homeostasis, modulates immune function, and supports overall well-being. Incorporating B. longum supplementation into holistic approaches to health and wellness may pave the way for a healthier future, where the gut microbiome is nurtured and optimized for optimal vitality and longevity.

 

References

  • Suez, Jotham, et al. “The Pros, Cons, and Many Unknowns of Probiotics.” Nature Medicine, vol. 25, 2019, pp. 716–729. Nature, https://www.nature.com/articles/s41591-019-0434-9.

  • Ohland, Christina L., and Wolfgang A. Kunze. “Effects of Lactobacilli and Bifidobacteria on the Nervous System.” Advances in Experimental Medicine and Biology, vol. 817, 2014, pp. 175-191. PubMed, https://pubmed.ncbi.nlm.nih.gov/24997043/.

  • Ouwehand, Arthur C., et al. “Probiotics: An Overview of Beneficial Effects.” Antonie van Leeuwenhoek, vol. 82, 2002, pp. 279-289. PubMed, https://pubmed.ncbi.nlm.nih.gov/12369194/.

  • Wang, Bo, et al. “Probiotics Modulate Gut Microbiota and Health: A Comprehensive Assessment.” Clinical Reviews in Allergy & Immunology, vol. 58, no. 1, 2020, pp. 1-17. PubMed, https://pubmed.ncbi.nlm.nih.gov/30737554/.

  • Elshaghabee, F. M. F., et al. “Bifidobacterium longum and Health Benefits: An Updated Review.” Journal of Functional Foods, vol. 40, 2018, pp. 1-8. PubMed, https://pubmed.ncbi.nlm.nih.gov/30559974/.

  • Hill, Colin, et al. “Expert Consensus Document: The International Scientific Association for Probiotics and Prebiotics Consensus Statement on the Scope and Appropriate Use of the Term Probiotic.” Nature Reviews Gastroenterology & Hepatology, vol. 11, 2014, pp. 506-514. Nature, https://www.nature.com/articles/nrgastro.2014.66.

  • Ventura, Marco, et al. “Genomics of Actinobacteria: Tracing the Evolutionary History of an Ancient Phylum.” Microbiology and Molecular Biology Reviews, vol. 71, no. 3, 2007, pp. 495-548. PubMed, https://pubmed.ncbi.nlm.nih.gov/17804669/.

  • Mazmanian, Sarkis K., et al. “Gut Microbiota Shapes Immune Responses during Health and Disease.” Nature Reviews Immunology, vol. 8, 2008, pp. 600-609. Nature, https://www.nature.com/articles/nri2414.

  • Preidis, Geoffrey A., and Jennifer A. Versalovic. “Targeting the Human Microbiome with Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era.” Gastroenterology, vol. 136, no. 6, 2009, pp. 2015-2031. PubMed, https://pubmed.ncbi.nlm.nih.gov/19457424/.

  • Ruiz, L., et al. “Human Gut Microbiota Composition Is Modifiable by Diet.” Current Opinion in Biotechnology, vol. 37, 2016, pp. 50-60. PubMed, https://pubmed.ncbi.nlm.nih.gov/26620222/.

  • O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., & Quigley, E. M. M. (2005). Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology, 128(3), 541-551. https://www.gastrojournal.org/article/S0016-5085(05)00144-3/fulltext

  • Saarela, M., Mogensen, G., Fondén, R., Mättö, J., & Mattila-Sandholm, T. (2000). Probiotic bacteria: Safety, functional and technological properties. Journal of Biotechnology, 84(3), 197-215. https://pubmed.ncbi.nlm.nih.gov/11164264/

  • Fedorak, R. N., & Madsen, K. L. (2004). Probiotics and the management of inflammatory bowel disease. Inflammatory Bowel Diseases, 10(3), 286-299. https://academic.oup.com/ibdjournal/article/10/3/286/4691370

  • Russo, E., & Sartor, R. B. (2010). Commensal bacteria as targets in Crohn’s disease. Current Opinion in Gastroenterology, 26(4), 318-322. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894667/

  • Scalabrin, D. M., Harris, C. L., Johnston, W. H., Berseth, C. L., & Petterson, G. M. (2012). Long-term safety assessment in children who received bifidobacteria and lactoferrin-supplemented formula. Journal of Pediatric Gastroenterology and Nutrition, 54(2), 257-262. https://journals.lww.com/jpgn/Abstract/2012/02000/Long_Term_Safety_Assessment_in_Children_Who.16.aspx

  • Dong, H., Rowland, I., & Tuohy, K. M. (2010). Bifidobacteria Modulate the Gut Microbial Composition and Alter the Expression of Genes Involved in Colorectal Cancer Pathways. Gut Microbes, 1(3), 190-199. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036515/

  • Saavedra, J. M., Bauman, N. A., Oung, I., Perman, J. A., & Yolken, R. H. (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to Infants in Hospital for Prevention of Diarrhea and Shedding of Rotavirus. Journal of Pediatric Gastroenterology and Nutrition, 21(4), 352-358. Retrieved from https://pubmed.ncbi.nlm.nih.gov/7860936/

  • Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., … & Singh, N. (2009). The Probiotic Preparation, VSL#3 Induces Remission in Patients with Mild-to-Moderately Active Ulcerative Colitis. Clinical Gastroenterology and Hepatology, 7(11), 1202-1209. Retrieved from https://pubmed.ncbi.nlm.nih.gov/19631292/

  • Marteau, P., de Vrese, M., Cellier, C. J., & Schrezenmeir, J. (2001). Protection from Gastrointestinal Diseases with the Use of Probiotics. American Journal of Clinical Nutrition, 73(2), 430S-436S. Retrieved from https://pubmed.ncbi.nlm.nih.gov/11157352/

  • Binns, N., & Howarth, G. S. (2013). Bifidobacteria in Food: Probiotics and Prebiotics. British Journal of Nutrition, 109(S2), S87-S90. Retrieved from https://pubmed.ncbi.nlm.nih.gov/23631386/

  • Ouwehand, A. C., Salminen, S., & Isolauri, E. (2002). Probiotics: An Overview of Beneficial Effects. Antonie Van Leeuwenhoek, 82(1-4), 279-289. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12369194/

intentional wellness integrative health practitioner logo

Further Reading on Gut Health:


Didn’t see what you are looking for? Try searching this site with Google below.

Related Posts